<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00714454</url>
  </required_header>
  <id_info>
    <org_study_id>97269358-APS</org_study_id>
    <nct_id>NCT00714454</nct_id>
  </id_info>
  <brief_title>5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris</brief_title>
  <official_title>5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris: A Double-Blind, Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ikeno Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      12-week study to compare the efficacy and safety of a course of a twice daily treatment with&#xD;
      APS in the form of a lotion to its vehicle for the treatment of acne.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>2</number_of_arms>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>APS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>APS Topical Lotion</intervention_name>
    <arm_group_label>APS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Vehicle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has read, understood, and signed appropriate informed consent, photo consent,&#xD;
             and HIPAA consent in their own language.&#xD;
&#xD;
          -  Subject has visible mild to severe acne, as assessed by the investigator.&#xD;
&#xD;
          -  Subject will be available and willing to return for follow-up visits.&#xD;
&#xD;
          -  Subject agrees not to use any other acne treatment products during the study.&#xD;
&#xD;
          -  Subject is otherwise healthy, non-febrile, and is not suffering from an infection&#xD;
             likely to require antibiotic therapy during the study period.&#xD;
&#xD;
          -  Subject or guardian must be able to understand the new HIPAA regulations and sign the&#xD;
             HIPAA form.&#xD;
&#xD;
          -  Subject is between the ages of 18 and 39.&#xD;
&#xD;
          -  Subject agrees and understands that APS or its vehicle is to be applied to the subject&#xD;
             twice daily for 12 weeks; no other topical or systemic medication affecting the course&#xD;
             of acne and/or evaluability is to be used during the study.&#xD;
&#xD;
          -  Subject agrees to use only the cleanser, moisturizer with sunscreen, and treatment&#xD;
             provided by the study site for the duration of the study.&#xD;
&#xD;
          -  Subject understands and agrees that he/she can not be treated with a systemic&#xD;
             antibiotic for acne during the study.&#xD;
&#xD;
          -  Subject agrees he/she will not use an acne topical treatment for two weeks prior to&#xD;
             Day 0.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject or guardian has not signed informed consent, photo consent or HIPAA form.&#xD;
&#xD;
          -  Subject is suffering from a condition likely to require medical attention, including&#xD;
             administration of oral or systemic antibiotics, oral or systemic corticosteroids, or&#xD;
             any other treatment which in the opinion of the investigator could influence the&#xD;
             results of the study.&#xD;
&#xD;
          -  Subject is pregnant or lactating.&#xD;
&#xD;
          -  Subject is suffering from an abnormal skin condition not usually associated with acne.&#xD;
&#xD;
          -  Subject will not be available for follow-up visits.&#xD;
&#xD;
          -  Subject has been previously enrolled in any clinical study in which treatment was&#xD;
             received within the past 30 days.&#xD;
&#xD;
          -  Subjects without comedones, papules, pustules, or nodules.&#xD;
&#xD;
          -  Subject has a history of hypersensitivity to any other ingredients of the study&#xD;
             lotion.&#xD;
&#xD;
          -  Subject has a history of anaphylaxis.&#xD;
&#xD;
          -  Subject is not able to avoid excessive sun exposure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Woolery-Lloyd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami Cosmetic Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <study_first_submitted>July 3, 2008</study_first_submitted>
  <study_first_submitted_qc>July 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2008</study_first_posted>
  <last_update_submitted>July 11, 2008</last_update_submitted>
  <last_update_submitted_qc>July 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

